Uploaded August 2026 | Updated November 2026, 3 days ago
Dr. Bonni Goldstein (Goldstein Wellness) presents "Cannabinoids in Sports and Recovery: Emerging Science and Clinical Applications" at CannMed 2026, covering pain modulation, inflammation, and neuroprotection.
There is a growing body of research on cannabinoids in athletic performance, recovery, and injury management. Clinicians will learn how cannabinoids influence pain modulation, inflammation, sleep, and neuroprotection, as well as their potential role in enhancing recovery and reducing reliance on opioids and NSAIDs. The discussion also addresses product selection and evidence-based guidance for advising athletes and active patients.
Dr. Bonni Goldstein, MD is the Medical Director of Canna-Centers Wellness & Education, a leading cannabis medicine specialty practice, and the CEO of GoldsteinWellness.com.
This talk was part of the CannMed Medical Practicum, a full-day educational program for clinicians and professionals expanding their expertise in medical cannabis, covering the endocannabinoid system, cannabinoid therapeutics, minor cannabinoids, product formulation, and more, led by a faculty of internationally recognized physicians and researchers.
This presentation was given at the CannMed 2026 Innovation & Collaboration Summit, held June 15-18 at the Hyatt Regency Lake Tahoe Resort. Visit cannmedevents.com to learn more.
Dr. Bonni Goldstein (Goldstein Wellness) presents "Cannabinoids in Sports and Recovery: Emerging Science and Clinical Applications" at CannMed 2026, covering pain modulation, inflammation, and neuroprotection.
There is a growing body of research on cannabinoids in athletic performance, recovery, and injury management. Clinicians will learn how cannabinoids influence pain modulation, inflammation, sleep, and neuroprotection, as well as their potential role in enhancing recovery and reducing reliance on opioids and NSAIDs. The discussion also addresses product selection and evidence-based guidance for advising athletes and active patients.
Dr. Bonni Goldstein, MD is the Medical Director of Canna-Centers Wellness & Education, a leading cannabis medicine specialty practice, and the CEO of GoldsteinWellness.com.
This talk was part of the CannMed Medical Practicum, a full-day educational program for clinicians and professionals expanding their expertise in medical cannabis, covering the endocannabinoid system, cannabinoid therapeutics, minor cannabinoids, product formulation, and more, led by a faculty of internationally recognized physicians and researchers.
This presentation was given at the CannMed 2026 Innovation & Collaboration Summit, held June 15-18 at the Hyatt Regency Lake Tahoe Resort. Visit cannmedevents.com to learn more.










![Demystifying Cannabinoid Hyperemesis Syndrome with Codi Peterson, PharmD
Dr. Codi Peterson is a pediatric pharmacist with over a decade of experience specializing in acute care and pediatric emergency medicine. He currently serves as a clinical pharmacist at Radys Childrens Health of Orange County, where he works night shifts in the Emergency Department and applies his expertise to optimize medication safety and therapeutic outcomes in children. Beyond the hospital, Codi is deeply committed to education and mentorship. He is an Associate Clinical Professor at the University of California, Irvine, where he teaches cannabis pharmacology and therapeutics, and a guest lecturer at OCEMT, instructing paramedics and firefighters in applied pharmacology.
He is also an active researcher on Cannabinoid Hyperemesis Syndrome (CHS), having led one of the largest patient surveys on the condition to date. At CannMed 26, Codi will share the results of that study in a presentation titled, “Through the Eyes of a Patient: Integrating Story and Science to Demystify CHS”.
During our conversation, we discuss:
- Defining CHS and explaining why it is difficult to research
- Cannabis use patterns among CHS sufferers
- Whether contaminants and pesticides play a role in developing CHS
- The prodromal phase and early warning signs of CHS
- Sex-based differences in CHS patients
- Understanding the biological mechanisms behind the development of CHS
- and more
Thanks to This Episodes Sponsor: The Cannigma
The Cannigma takes an evidence-based approach to cannabis content – from safety to cooking to medical research – and makes all the information digestible and useful.
They are committed to making sure scientific information is accessible to anyone who needs it – be it to relieve their own suffering or that of a loved one, to learn a bit more, or even just for fun.
Learn more at cannigma.com
Additional Resources
- Surveying Cannabinoid Hyperemesis Syndrome Patients with Megan Mbengue and Codi Peterson [Video] - https://youtu.be/ez7PyEESrSU
- Cannabinoid Hyperemesis Syndrome What You Need to Know [Video] - https://youtu.be/9hCp6puJvXc?si=Gc14ELLhC3S5KOBL
- what-is-chs.com
- Codi on IG - https://www.instagram.com/cannabispharmd/
- Codi on LinkedIn - https://www.linkedin.com/in/cannapharmd/
- The Cannigma - cannigma.com
- Register for CannMed 26 - Early Bird Ends February 20th! - https://cannmedevents.com/package-options/ Demystifying Cannabinoid Hyperemesis Syndrome with Codi Peterson, PharmD](https://i.ytimg.com/vi/bIZi75xoUyk/mqdefault.jpg)